SCHEMBL25979153

SCHEMBL25979153

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(-c5cccc(N(c6ccccc6)c6ccccc6)c5)cc34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
MMP12 P39900 2/20 0.36
HCRTR1 O43613 1/20 0.36
CHEK2 O96017 1/20 0.35
PLA2G10 O15496 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 2/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979224 0.99 PLA2G2A (0.36) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL26779128 0.97 PLA2G2A (0.35) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL25978971 0.97 PLA2G2A (0.35) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL25978744 0.95 GAA (0.35) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL25978683 0.95 GAA (0.35) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL25979738 0.95 MEN1 (0.37) MMP12HCRTR1MEN1KMT2AALDH1A1
SCHEMBL25978745 0.94 GAA (0.36) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL24574978 0.94 PLA2G2A (0.38) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL25978970 0.94 PLA2G2A (0.38) PLA2G2APLA2G4AMMP12HCRTR1CHEK2
SCHEMBL26416734 0.94 PLA2G2A (0.38) PLA2G2APLA2G4AMMP12HCRTR1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 PLA2G2A 4090/4885PLA2G4A 4219/4885MMP12 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.